Evidence map›Paper›PMID 30804613›Full record

ArticleRadiologia brasileira

Is interim

Elba Etchebehere, Ana Emília Brito, Kalevi Kairemo, Eric Rohren, John Araujo, Homer Macapinlac

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Radiologia brasileira. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Trial
  2. Theranostics Nuclear Medicine in Prostate Cancer.Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Elba EtchebehereUniversidade Estadual de Campinas (Unicamp), Campinas, SP, Brazil.ORCID https://orcid.org/0000-0002-8632-5943
Ana Emília BritoReal Hospital Português de Beneficência em Pernambuco - Real Nuclear, Recife, PE, Brazil.ORCID https://orcid.org/0000-0002-1065-9672
Kalevi KairemoThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID https://orcid.org/0000-0002-5194-746X
Eric RohrenThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID https://orcid.org/0000-0002-9788-6471
John AraujoThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Homer MacapinlacThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.
The University of Texas MD Anderson Cancer Center · USReal Hospital Português · BRUniversidade Estadual de Campinas (UNICAMP) · BR

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8M
NCI NIH HHS P30 CA016672
6 · The paper itself

Abstract

objectiveTo determine whether an interim MATERIALS AND

methodsWe retrospectively reviewed 34 histologically confirmed cases of hormone-refractory prostate cancer with bone metastasis in patients submitted to

resultsThe mean age of the patients was 72.4 ± 10.2 years (range, 43.3-88.8 years). The %TLF

conclusionThe skeletal tumor burden on an interim

Indexed as

Bone neoplasms/diagnostic imagingPositron-emission tomography/methodsProstatic neoplasmsRadium-223Sodium fluorideTomography, X-ray computed/methodsTumor burden

Identifiers

PMID30804613
PMCPMC6383535
OpenAlexW2915340217

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.